Back to Trials
NCT07098858Recruiting

The WiSE®-UP Registry (The WiSE System Utilization & Performance Registry)

EBR Systems, Inc.

Start Date

11/3/2025

Completion Date

9/30/2032

Summary

Observe to understand product performance, including patient safety, clinical outcomes, and CRT response information associated with the use of the market-released WiSE System

Detailed Description

The WiSE-UP Registry is a prospective, real-world, observational study aimed at understanding acute and long-term product performance, including patient safety, clinical outcomes, and CRT response information associated with the use of the market-released WiSE System.

Eligibility Criteria

Age Range: No minimum to No maximum

* Patient or legally authorized representative can provide written authorization and/or consent per institution requirements. * Patient is intended to receive a WiSE System and passed the acoustic window screening * Patient who is, or will be, accessible for follow-up. * Participation is not excluded by local law. * Patient is not enrolled in a concurrent drug and/or device study that may confound the Registry results. * Patient life expectancy \>1 year.

Interventions

DEVICE

The Wise System

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Heart Failure

Locations

Arrhythmia Research Group (St. Bernards Hospital)

Jonesboro, Arkansas 72404

United States

Naples Community Hospital

Naples, Florida 34102

United States

University of Michigan

Ann Arbor, Michigan 48107

United States

Weill Cornell Medicine

New York, New York 10021

United States

Penn State Health

Hershey, Pennsylvania 17033

United States